BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/3/2026 6:28:06 AM | Browse: 1 | Download: 1
 |
Received |
|
2025-09-26 11:12 |
|
Peer-Review Started |
|
2025-09-26 11:15 |
|
First Decision by Editorial Office Director |
|
2025-10-30 09:25 |
|
Return for Revision |
|
2025-10-30 10:40 |
|
Revised |
|
2025-11-09 11:07 |
|
Publication Fee Transferred |
|
2025-11-11 09:37 |
|
Second Decision by Editor |
|
2025-12-15 02:45 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-15 06:01 |
|
Articles in Press |
|
2025-12-15 06:01 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-01-26 08:24 |
|
Publish the Manuscript Online |
|
2026-02-03 06:28 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Efficacy and safety of integrated Chinese and Western medicine in advanced pancreatic cancer: A double-center retrospective cohort study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ying-Rui Wang, Jin-Qiu Wang, Xue-Jiao Chen, Yu Yan, Yu Zhang, Meng-Yi Li, Wei Wang, Tian-Yu Fan, Peng-Fei Jiao and Chao-Feng Zhou |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Chao-Feng Zhou, Chief Physician, Department of Oncology, Henan Provincial Hospital of Traditional Chinese Medicine, No. 6 Dongfeng Road, Zhengzhou 450000, Henan Province, China. doctorzcf@126.com |
| Key Words |
Advanced pancreatic cancer; Integrated Chinese and Western medicine; Retrospective cohort study; Survival duration; Short-term outcomes; Long-term outcomes; Safety |
| Core Tip |
Advanced pancreatic cancer (PC) is associated with poor prognosis. In this double-center retrospective cohort study, the median survival time in the Western medicine (WM) group was 10.67 months, while the integration of Chinese and WM group demonstrated an additional 2.24 months of survival. This breakthrough exceeded the conventional 12-month median survival time threshold for PC, nearing the survival outcomes achieved with targeted immunotherapy and combination chemotherapy, which are at the forefront of precision treatments. These findings suggest that integrated Chinese and WM models may provide survival advantages to patients with advanced PC. |
| Publish Date |
2026-02-03 06:28 |
| Citation |
Wang YR, Wang JQ, Chen XJ, Yan Y, Zhang Y, Li MY, Wang W, Fan TY, Jiao PF, Zhou CF. Efficacy and safety of integrated Chinese and Western medicine in advanced pancreatic cancer: A double-center retrospective cohort study. World J Gastrointest Oncol 2026; 18(2): 114690 |
| URL |
https://www.wjgnet.com/1948-5204/full/v18/i2/114690.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v18.i2.114690 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
